Intralesional chloroquine in cutaneous leishmaniasis
DOI:
https://doi.org/10.66344/jpad.15.1.2005.612Keywords:
Saal-dana, cutaneous leishmaniasis, intralesional chloroquine, single lesionAbstract
Background Cutaneous Leishmaniasis (CL) is endemic in certain areas of Pakistan .This
study was carried out to determine the efficacy of intralesional chloroquine in CL.
Patients and methods CL patients with single lesion presenting to Leishmaniasis clinic of
Tehsil Headquarter Hospital, Sadda from 1st December, 2003 to 30thMarch, 2004 and
subsequently to outpatient department of Hayatabad Medical Complex, Peshawar, were
included in the study. The patients were diagnosed clinically and by laboratory confirmation
of parasites in a Giemsa – stained smear prepared from the lesion. All important clinical
details were recorded on a specially designed pro forma and patients were registered for the
purpose of treatment and a card was issued to them for subsequent visits and follow up.
Twelve atients were treated with intralesional chloroquine thrice weekly for three weeks.
Results All patients were declared cured on the basis of clinical and pathological criteria at 7
weeks (4 weeks after the completion of therapy). No adverse effects were observed.
Conclusion Intralesional chloroquine was found to be safe and cost-effective therapy for
single lesion of cutaneous leishmaniasis. Intralesional chloroquine was used for the first time
in the treatment of CL.
References
Mujtaba G, Khalid M. Cutaneous
Leishmaniasis in Multan, Pakistan. Int J
Dermatol 1998; 37: 843-6.
Jaffrany M, Haroon TS. Cutaneous
leishmaniasis in Pakistan. Biomedica
; 8: 39-44.
Rahim F, Jamal S, Raziq F et al. An
outbreak of cutaneous Leishmaniasis in
a village of District Dir, N.W.F.P. J
Postgrad Med Inst 2003; 17: 85-8.
World Health Organization (WHO).
Report of Committee. The
Leishmaniasis: World Health Tech Rep
Ser 701, 1984.
Kubba R, Gindan YA. Leishmaniasis.
Dermatol Clin 1989; 7:331-50.
Kolaczinski J, Brooker S, Reyburn H,
Rowland M. Epidemiology
anthroponotic cutaneous leishmaniasis
in Afghan reefugee camps in northwest
Pakistan. Trans R Soc Trop Med Hyg
; 98: 373-8.
Bari AU, Rahman SB. A therapeutic
update on Cutaneous Leishmaniasis. J
Coll Physicians Surg Pak 2003; 13:
-8.
Bogenzieder T, Lehn N, Landthaler M,
Stolz W. Treatment of Old World
cutaneous leishmaniasis with
Intralesionally injected meglumine
antimonite using a dermojet device.
Dermatology 2003; 206: 269-72.
Hussain AB, Amanullah, Dil AF et al.
The efficacy of intralesional sodium
stibogluconate with glucantime. Pak J
Med Res 2002; 41: 54-7.
Kellum RE . Treatment of Cutaneous
Leishmaniasis with an intralesional
drug (Pentostam). J Am Acad Dermatol
: 15: 620-2.
Downloads
Published
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
